Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

With Renvela, Genzyme Wants To Grow Market, But Not Necessarily Share

Oct 29 2007

• By Cathy Dombrowski

Related Content

Shire Fosrenol Clears FDA For ESRD; Kidney Stone Studies May Be Next

Nov 01 2004

Phosphate Binders Need To Show Clinical Benefit For Pre-Dialysis – Cmte.

Oct 22 2007

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window